line]. Available: [accessed January 2000].

Unwin C, Blatchley N, Coker W, Ferry S, Hotopf M, Hull L, Ismail K, Palmer I, David A, Wessely S. 1999. Health of UK servicemen who served in Persian Gulf War. Lancet 353(9148):169–178.

USAMRIID (U.S. Army Medical Research Institute of Infectious Diseases). 1996. Medical Management of Biological Casualties: Handbook. 2nd edition. Fort Detrick, MD: USAMRIID.

U.S. Department of the Air Force. 1995. Air Force Joint Instruction 48-110. Aerospace Medicine: Immunizations and Chemoprophylaxis (Army Regulation 40-5622/ Bumedinst6230.15/CG COM DINST M6230.4E). November 1, 1995.

U.S. DHHS (Department of Health and Human Services). 1990. Informed consent for human drugs and biologics: Determination that informed consent is not feasible. Federal Register 55(246):52814.

Webb M. 1997. Re: Multiple vaccination. J R Soc Health 117(6):401.

Welkos SL. 1987. Protective Efficacy and Safety of Live Anthrax Vaccines for Mice. Fort Detrick, MD: U.S. Army Medical Research Institute of Infectious Diseases. Available from the National Technical Information Service. AD–A190 150/3.

Welkos SL, Friedlander AM. 1988. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microbial Pathogenesis 5(2):127–139.

Whalen RL, Dempsey DJ, Thompson LM, Bucknell K, Kunitomo R, Okazaki Y, Harasaki H. 1996. Microencapsulated vaccines to provide prolonged immunity with a single administration. ASAIO J 42(5):M649–M654.

White CS, Adler WH, McGann VG. 1974. Repeated immunization: Possible adverse effects. Ann Intern Med 81(5):594–600.

Whitehouse M, Orr K, Beck F, Pearson C. 1974. Freund’s adjuvants: Relationship of arthritogenicity and adjuvanticity in rats to vehicle composition. Immunology 27: 311–330.

Whitford HW. 1987. A Guide to the Diagnosis, Treatment, and Prevention of Anthrax. WHO/ZOON./87.163. Geneva: World Health Organization.

Wright GG, Green TW, Kanode RG Jr. 1954. Studies on immunity in anthrax. V. Immunizing activity of alum-precipitated protective antigen. J Immunol 73:387–391.

Yefremova VN. 1980. Experimental study of skin-sensitizing antibodies after aerosol and subcutaneous immunization. J Hyg Epidemiol Microbiol Immunol 24(1):29–35.

Yoshino S. 1996. Oral administration of type II collagen suppresses non-specifically induced chronic arthritis in rats. Biomed Pharmacother 50(1):24–28.

Yoshino S, Yoshino J. 1994. Recruitment of pathogenic T cells to synovial tissues of rats injected intraarticularly with nonspecific agents. Cell Immunol 158(2):305–313.

Zilinskas RA. 1997. Iraq’s biological weapons: The past as future? JAMA 278:418–424.

Zuffa A, Banda I, Konrad J. 1972. Combined vaccination of mink against Aujeszky’s disease and botulism. Zentralbl Veterinarmed [B] 19(9):728–738.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement